NR4A1 inhibition synergizes with ibrutinib in killing mantle cell lymphoma cells

被引:2
|
作者
Li, Yangguang [1 ,2 ]
Wang, Fangyu [1 ,2 ]
Lu, Li [1 ,2 ]
Zhu, Fen [1 ,2 ]
Huang, Shengjian [3 ]
Nomie, Krystle [3 ]
Zhang, Liang [3 ]
Yang, David T. [2 ,4 ]
Huang, Wei [4 ]
Kahl, Brad S. [5 ]
Safe, Stephen [6 ]
Wang, Michael [3 ]
Rui, Lixin [1 ,2 ]
机构
[1] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53792 USA
[2] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI 53792 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[4] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI 53792 USA
[5] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[6] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA
来源
BLOOD CANCER JOURNAL | 2017年 / 7卷
关键词
NUCLEAR RECEPTORS; CANCER; APOPTOSIS; SURVIVAL; BCL-2; BTK;
D O I
10.1038/s41408-017-0005-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Flavonoids Quercetin and Kaempferol Are NR4A1 Antagonists and Suppress Endometriosis in Female Mice
    Zhang, Lei
    Mohankumar, Kumaravel
    Martin, Gregory
    Mariyam, Fuada
    Park, Yuri
    Han, Sang Jun
    Safe, Stephen
    ENDOCRINOLOGY, 2023, 164 (10)
  • [32] Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma
    Zhao, Xiaohong
    Wang, Michelle Y.
    Jiang, Huijuan
    Lwin, Tint
    Park, Paul M.
    Gao, Jing
    Meads, Mark B.
    Ren, Yuan
    Li, Tao
    Sun, Jiao
    Fahmi, Naima Ahmed
    Singh, Satishkumar
    Sehgal, Lalit
    Wang, Xuefeng
    Silva, Ariosto S.
    Sotomayor, Eduardo M.
    Shain, Kenneth H.
    Cleveland, John L.
    Wang, Michael
    Zhang, Wei
    Qi, Jun
    Shah, Bijal D.
    Tao, Jianguo
    CELL REPORTS, 2021, 34 (11):
  • [33] The Nuclear Orphan Receptor NR4A1 and NR4A3 as Tumor Suppressors in Hematologic Neoplasms
    Wenzl, Kerstin
    Troppan, Katharina
    Neumeister, Peter
    Deutsch, Alexander J. A.
    CURRENT DRUG TARGETS, 2015, 16 (01) : 38 - 46
  • [34] ISG12a and its interaction partner NR4A1 are involved in TRAIL-induced apoptosis in hepatoma cells
    Liu, Nianli
    Wu, Zhiyuan
    Chen, Aoxing
    Chai, Dafei
    Li, Liantao
    Zhang, Longzhen
    Zheng, Junnian
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (05) : 3520 - 3529
  • [35] Identification of a Multipotent Progenitor Population in the Spleen That Is Regulated by NR4A1
    Mumau, Melanie D.
    Vanderbeck, Ashley N.
    Lynch, Elizabeth D.
    Golec, Sophia B.
    Emerson, Stephen G.
    Punt, Jennifer A.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (03) : 1078 - 1087
  • [36] Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial
    Le Gouill, Steven
    Morschhauser, Franck
    Chiron, David
    Bouabdallah, Krimo
    Cartron, Guillaume
    Casasnovas, Olivier
    Bodet-Milin, Caroline
    Ragot, Sylviane
    Bossard, Celine
    Nadal, Nathalie
    Herbaux, Charles
    Tessoulin, Benoit
    Tchernonog, Emmanuelle
    Rossi, Cedric
    McCulloch, Rory
    Gastinne, Thomas
    Callanan, Mary B.
    Rule, Simon
    BLOOD, 2021, 137 (07) : 877 - 887
  • [37] HSP90 Inhibitor Ganetespib Enhances the Sensitivity of Mantle Cell Lymphoma to Bruton's Tyrosine Kinase Inhibitor Ibrutinib
    Lu, Ziwen
    Wang, Zhixin
    Tu, Zhigang
    Liu, Hanqing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [38] SPDEF suppresses head and neck squamous cell carcinoma progression by transcriptionally activating NR4A1
    Wang, Yanting
    Ren, Xianyue
    Li, Weiyu
    Cao, Ruoyan
    Liu, Suyang
    Jiang, Laibo
    Cheng, Bin
    Xia, Juan
    INTERNATIONAL JOURNAL OF ORAL SCIENCE, 2021, 13 (01)
  • [39] Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines
    Alexopoulou, Annika N.
    Leao, Maria
    Caballero, Otavia L.
    Da Silva, Leonard
    Reid, Lynne
    Lakhani, Sunil R.
    Simpson, Andrew J.
    Marshall, John F.
    Neville, A. Munro
    Jat, Parmjit S.
    BREAST CANCER RESEARCH, 2010, 12 (04)
  • [40] Nr4a1: A multilevel target to overcome PGD in lung transplantation
    Vanluyten, Cedric
    Vos, Robin
    Ceulemans, Laurens J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2025, 44 (02) : 261 - 262